1. Home
  2. DX vs VERA Comparison

DX vs VERA Comparison

Compare DX & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dynex Capital Inc.

DX

Dynex Capital Inc.

HOLD

Current Price

$14.03

Market Cap

1.7B

Sector

Real Estate

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$44.90

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DX
VERA
Founded
1987
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
DX
VERA
Price
$14.03
$44.90
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$13.33
$63.13
AVG Volume (30 Days)
4.9M
1.8M
Earning Date
10-20-2025
11-05-2025
Dividend Yield
14.54%
N/A
EPS Growth
35.65
N/A
EPS
1.66
N/A
Revenue
$230,447,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$134.14
N/A
P/E Ratio
$8.46
N/A
Revenue Growth
87.09
N/A
52 Week Low
$10.79
$18.53
52 Week High
$14.52
$49.77

Technical Indicators

Market Signals
Indicator
DX
VERA
Relative Strength Index (RSI) 67.11 81.00
Support Level $13.80 $32.66
Resistance Level $14.06 $34.43
Average True Range (ATR) 0.18 2.64
MACD 0.02 1.68
Stochastic Oscillator 97.09 95.26

Price Performance

Historical Comparison
DX
VERA

About DX Dynex Capital Inc.

Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: